Glaukos touts 2-year iStent inject pivotal trial data, levies infringement suit against Ivantis

April 16, 2018 By Fink Densford Leave a Comment

Glaukos (NYSE:GKOS) today released two-year data from the FDA investigational device exemption pivotal trial of its iStent inject trabecular micro-bypass system, and announced a patent infringement suit it filed against Ivantis.

Results of the 505-patient study were presented at the American Society of Cataracts and Refractive Surgery annual meeting by Dr. Thomas Samuelson of the Minnesota Eye Consultants, the San Clemente, Calif.-based company said.

The iStent inject trabecular micro-bypass system is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pair of heparin-coated titanium stents in a pre-loaded auto-injection system that allows them to be injected into multiple trabecular meshwork locations via a single corneal entry point, the company said.

In the trial, subjects were randomized to two cohorts, with 387 patients receiving the iStent inject in combination with cataract surgery and 118 patients receiving cataract surgery only. Subjects in the trial were followed through two years with annual medication washouts, the company said.

Glaukos said that the trial met its primary and secondary effectiveness endpoints, and reported that the overall rate of adverse events between groups was similar.

At two years, 75.3% of the cohort who received the iStent inject achieved a 20% or greater reduction in unmedicated intraocular pressure compared to 61.9% in the cataract-surgery-only cohort. Mean unmedicated IOP amongst iStent patients was 6.9 mmHg compared to 5.4 mmHg for the cataract-only cohort.

Data indicated that at two years, the iStent inject cohort had a 31% mean reduction in unmedicated IOP of 17.11 mmHg from a baseline of 24.8 mmHG and that 62.6% of the cohort achieved an unmedicated mean IOP at or below 18 mmHg, compared to only 49.2% in the cataract-surgery-only cohort.

“The IOP-lowering capability of a single iStent in combination with cataract surgery has been well documented in the clinical literature, while various published studies and real-world international experience have also shown that multiple iStent devices can provide incremental IOP-lowering benefits. Given its performance and enhanced ease-of-use, we believe the iStent inject, if approved by the FDA, will be an attractive, two-stent option for U.S. ophthalmic surgeons to reliably manage glaucoma patients’ IOP in a straightforward and effective manner,” prez & CEO Thomas Burns said in a press release.

In a separate release, Glaukos announced it filed a patent infringement suit in the US District Court for the Central District of California, Southern division, against competitor Ivantis.

In the suit, the company claims that Ivantis’ Hydrus Microstent device infringes on patents Glaukos owns related to its core glaucoma technology.

“Since our founding in 1998, Glaukos has invested considerable time and resources to develop novel technologies that create entirely new treatment options for glaucoma surgeons and their patients. This lawsuit reflects our unwavering commitment to protect our proprietary inventions for the benefit of patients, customers, shareholders, employees and others who rely on us,” CEO Burns said in a prepared statement.

In February, Glaukos released results from a study of its iStent trabecular micro-bypass stent exploring its use during cataract surgery in patients with severe open-angle glaucoma, touting significant reductions in intraocular pressure and medication use.

With more than 30 speakers, 25 panels and 4 tracks, you can't miss DeviceTalks Minnesota

On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.

Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.

Use the code "DTWeb" to save 15% on the cost of registration.

REGISTER TODAY

ProVerum Medical closes $4.2M investment round
ProVerum Medical recently announced that it has closed a $4.2 million seed investment with Atlantic Bridge University Fund leading the investment round. Dublin-based ProVerum Medical, a startup company from Trinity College Dublin, received a number of investments from Irish and American angel investors like HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The $4.2 […]
Emerson launches new Branson welding workstations
Emerson recently announced that it has launched its modular, custom engineered Branson welding workstations to help make the deployment of clean, secure and ergonomic production areas easier. The modular workstations are customizable and feature a height-adjustable, anodized-aluminum worktable and an ergonomic platform that weld-system operators can comfortably work on while standing or sitting. The worktable […]
How 3D printed cells on the skin could enable wound healing
Researchers at the University of Minnesota are 3D printing electronics and cells directly on the skin that could create new methods for wound healing and enable biological agent detection. The Minnesota researchers used a customized, low-cost 3D printer to print electronics on a human hand. They’ve also successfully printed biological cells on a sin wound of […]
MW Industries acquires medical-component maker LaVezzi Precision
MW Industries, a provider of highly engineered springs, specialty fasteners, machined parts, and other precision components, has acquired LaVezzi Precision Inc. — manufacturer of precision-machined components used by the medical-device industry. Located in Bloomingdale, Ill., LaVezzi was founded more than 100 years ago as a manufacturer of components for motion-picture projectors. The company reinvented itself in… […]
Razorleaf opens first international division
Razorleaf (Stow, Ohio) announced that it has opened its first division outside of the U.S. in Northampton, U.K. The company’s new Razorleaf Europe will provide a single delivery and support service to customers in Europe. “We’ve already done projects in Europe, and have customers with both U.S. and European presence, but as we get into […]
MedAccred adds plastic extrusion to audit criteria
MedAccred recently announced that it has added plastics extrusion to its list of audit opportunities. Companies that want accreditation from MedAccred can now audit plastics extrusion in addition to cable and harness, heat treating, plastics injection molding, printed circuit board assembly, sterilization and welding. The audit criteria is developed from leaders in the medical device […]
This augmented reality system projects medical images on the body
Augmented reality is helping doctors visualize what’s inside the body without having to pick up a scalpel, thanks to a new system from the University of Alberta. The system ProjectDR projects medical images like CT scans and MRI data directly onto a patient’s body in a way that moves with the body. “We wanted to […]
What is a left ventricular assist device and how does it work?
What is a left ventricular assist device? A left ventricle assist device (LVAD) is a mechanical pump that attaches to the left ventricle of the heart to supplement the function of the pumping chamber, according to Jodi Hutchins, a regulatory and quality consultant at Proven Process Medical Devices. The left ventricle of the heart is responsible […]
How video games could take market share from big pharma
Tracy MacNeal, Ximedica At the Biotech Showcase in January, a panel discussed how video games are replacing drug therapies in a variety of diseases. If you haven’t seen the latest technology in this space, companies like Akili are providing drug-alternative therapies to kids with ADHD and Pear Therapeutics’ software is aimed at helping people with addiction. Technologists have reached incredible heights in getting people to […]
Tomorrow is Medical Alley Day in Minnesota
Minnesota Gov. Mark Dayton has declared tomorrow as Medical Alley Day in the state — the same day the state’s Medical Alley Association is holding its annual meeting in downtown Minneapolis. The North Star State is one of three major medical device hubs in the U.S., the other two being California and Massachusetts. Dayton noted in his […]
Nelson Labs expands lab operations at Illinois facility
Nelson Labs recently announced that it has invested in expanding its operations and service capabilities at its Itasca, Ill. facility. The investment will offer upgrades to the laboratory facilities, in addition to a 10,000 sq. ft building expansion and renovated lab space. The upgrades will include a BI sterility suite to support EO sterilization validations […]